摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

异烟酸-(2,6-二甲基苯胺) | 68280-05-7

中文名称
异烟酸-(2,6-二甲基苯胺)
中文别名
N-(2,6-二甲基苯基)-4-吡啶羧酰胺
英文名称
N-(2,6-dimethylphenyl)pyridine-4-carboxamide
英文别名
pyridine-4-formyl-(2,6-dimethyl)aniline;isonicotinic acid-(2,6-dimethyl-anilide);Isonicotinsaeure-(2,6-dimethyl-anilid);Pyridin-4-carbonsaeure-(2,6-dimethyl-anilid)
异烟酸-(2,6-二甲基苯胺)化学式
CAS
68280-05-7
化学式
C14H14N2O
mdl
MFCD01350148
分子量
226.278
InChiKey
TVCJRDMVAATRMN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    42
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    异烟酸-(2,6-二甲基苯胺) 在 gadolinium(III) chloride 作用下, 以 异丙醇乙腈 为溶剂, 70.0 ℃ 、530.01 kPa 条件下, 反应 2.17h, 以92%的产率得到piperidine-4-formyl-(2,6-dimethyl)aniline
    参考文献:
    名称:
    一种哌啶羧酸酰胺药物中间体哌啶-4-甲酰-(2,6-二甲基)苯胺的合成方法
    摘要:
    本发明公开了一种哌啶羧酸酰胺药物中间体哌啶‑4‑甲酰‑(2,6‑二甲基)苯胺的合成方法,通过将吡啶‑4‑甲酰‑(2,6‑二甲基)苯胺在异丙醇与乙腈混合溶液中,在降压、升温条件下与氯化钆反应,然后经降温、过滤、减压浓缩、分子筛脱色、脱水、重结晶,得到哌啶‑4‑甲酰‑(2,6‑二甲基)苯胺。该方法反应时间短、收率高,为该中间体提供了一种新的合成路线,为进一步提升反应收率打下了良好的基础。
    公开号:
    CN105906552A
  • 作为产物:
    描述:
    异烟酸氯化亚砜三乙胺 作用下, 以 四氢呋喃吡啶 为溶剂, 反应 1.0h, 生成 异烟酸-(2,6-二甲基苯胺)
    参考文献:
    名称:
    Synthesis and structure–activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores
    摘要:
    Using N-(2,6-dimethyl)phenyl-2-piperidinecarboxamide (1) and N-(alpha -methylbenzyl)-2-piperidinecarboxamide (2) as structural leads, a variety of analogues were synthesised and evaluated for anticonvulsant activity in the MES test in mice. In the N-benzyl series, introduction of 3-Cl, 4-Cl, 3,4-Cl-2, or 3-CF3 groups on the aromatic ring led to an increase in MES activity. Replacement of the alpha -methyl group by either i-Pr or benzyl groups enhanced MES activity with no increase in neurotoxicity. Substitution on the piperidine ring nitrogen led to a decrease in MES activity and neurotoxicity, while reduction of the amide carbonyl led to a complete loss of activity. Movement of the carboxamide group to either the 3- or 4-positions of the piperidine ring decreased MES activity and neurotoxicity. Incorporation of the piperidine ring into a tetrahydroisoquinoline or diazahydrinone nucleus led to increased neurotoxicity. In the N-(2,6-dimethyl)phenyl series, opening of the piperidine ring between the 1- and 6-positions gave the active norleucine derivative 75 (ED50 = 5.8 mg kg(-1), TD50 = 36.4 mg kg(-1), PI = 6.3). Replacement of the piperidine ring of I by cycloalkane (cyclohexane, cyclopentane, and cyclobutane) resulted in compounds with decreased MES activity and neurotoxicity, whereas replacement of the piperidine ring by a 4-pyridyl group led to a retention of MES activity with a comparable PI. Simplification of the 2-piperidinecarboxamide nucleus of 1 into a glycinecarboxamide nucleus led to about a six-fold decrease in MES activity. The 2,6-dimethylanilides were the most potent compounds in the MES test in each group of compounds evaluated, and compounds 50 and 75 should be useful leads in the development of agents for the treatment of tonic-clonic and partial seizures in man. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
    DOI:
    10.1016/s0223-5234(00)01206-x
点击查看最新优质反应信息

文献信息

  • Pd0/PR3-Catalyzed Arylation of Nicotinic and Isonicotinic Acid Derivatives
    作者:Masayuki Wasa、Brady T. Worrell、Jin-Quan Yu
    DOI:10.1002/anie.200906104
    日期:——
    Intermolecular CH functionalization of pyridine rings at the 3‐ and 4‐positions is described using a Pd0/PR3/ArBr catalytic system. This reaction provides a powerful method for the preparation of structurally diverse nicotinic and isonicotinic acids that are of great importance in drug discovery.
    有益于您的健康:使用 Pd 0 /PR 3 /ArBr 催化系统描述了 3 位和 4 位吡啶环的分子间 C  H 官能化。该反应为制备结构多样的烟酸和异烟酸提供了一种强有力的方法,这些酸和异烟酸在药物发现中具有重要意义。
  • 一种哌啶羧酸酰胺药物中间体N-(2,6-二甲基苯)-4-吡啶甲酰胺的合成方法
    申请人:成都卡迪夫科技有限公司
    公开号:CN105503714A
    公开(公告)日:2016-04-20
    一种哌啶羧酸酰胺药物中间体N-(2,6-二甲基苯)-4-吡啶甲酰胺的合成方法,包括如下步骤:在安装有搅拌器、温度计的反应容器中,加入吡啶-4-甲酰胺1.1mol,硝基甲烷600—620ml,控制搅拌速度130—160rpm,分批次加入溴化亚铜0.4—0.42mol,升高溶液温度至100--105℃,反应2—3h,过滤,将滤液重新加入反应容器,滴加2,6-二甲苯胺1.1—1.3mol,加完后维持搅拌速度5—6h,降低溶液温度至15--18℃,析出固体,过滤,固体用乙酸乙酯洗涤,得N-(2,6-二甲基苯)-4-吡啶甲酰胺溴酸盐,将该溴酸盐溶于1100ml硝酸钾溶液,分子筛脱色,加入亚硫酸钠溶液调节pH为9—10,降低溶液温度至3--5℃,析出固体,过滤,固体经过盐溶液洗涤,脱水剂脱水,在氯苯中重结晶,得N-(2,6-二甲基苯)-4-吡啶甲酰胺。
  • Neue Lokalanästhetika
    作者:H. Rinderknecht
    DOI:10.1002/hlca.19590420430
    日期:——
    The mixed anhydride method has been used successfully in the synthesis of a series of pyridinecarboxamides. Hydrogenation of some of these products furnished piperidinecarboxarnides which were found to possess excellent local anesthetic properties and low toxicities.
    混合酸酐法已成功用于一系列吡啶甲酰胺的合成中。这些产品中的一些加氢提供了哌啶甲酰胺,发现它们具有出色的局部麻醉性能和低毒性。
  • af Ekenstam et al., Acta Chemica Scandinavica (1947), 1957, vol. 11, p. 1183,1184
    作者:af Ekenstam et al.
    DOI:——
    日期:——
  • Synthesis and structure–activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores
    作者:Bin Ho、A Michael Crider、James P Stables
    DOI:10.1016/s0223-5234(00)01206-x
    日期:2001.3
    Using N-(2,6-dimethyl)phenyl-2-piperidinecarboxamide (1) and N-(alpha -methylbenzyl)-2-piperidinecarboxamide (2) as structural leads, a variety of analogues were synthesised and evaluated for anticonvulsant activity in the MES test in mice. In the N-benzyl series, introduction of 3-Cl, 4-Cl, 3,4-Cl-2, or 3-CF3 groups on the aromatic ring led to an increase in MES activity. Replacement of the alpha -methyl group by either i-Pr or benzyl groups enhanced MES activity with no increase in neurotoxicity. Substitution on the piperidine ring nitrogen led to a decrease in MES activity and neurotoxicity, while reduction of the amide carbonyl led to a complete loss of activity. Movement of the carboxamide group to either the 3- or 4-positions of the piperidine ring decreased MES activity and neurotoxicity. Incorporation of the piperidine ring into a tetrahydroisoquinoline or diazahydrinone nucleus led to increased neurotoxicity. In the N-(2,6-dimethyl)phenyl series, opening of the piperidine ring between the 1- and 6-positions gave the active norleucine derivative 75 (ED50 = 5.8 mg kg(-1), TD50 = 36.4 mg kg(-1), PI = 6.3). Replacement of the piperidine ring of I by cycloalkane (cyclohexane, cyclopentane, and cyclobutane) resulted in compounds with decreased MES activity and neurotoxicity, whereas replacement of the piperidine ring by a 4-pyridyl group led to a retention of MES activity with a comparable PI. Simplification of the 2-piperidinecarboxamide nucleus of 1 into a glycinecarboxamide nucleus led to about a six-fold decrease in MES activity. The 2,6-dimethylanilides were the most potent compounds in the MES test in each group of compounds evaluated, and compounds 50 and 75 should be useful leads in the development of agents for the treatment of tonic-clonic and partial seizures in man. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐